Lecture 31 & 32: Autoimmunity, Hypersensitivity, and Skin Flashcards

1
Q

Describe the structure of the skin

A

Skin is composed of three layers which are:

  • Epidermis (mainly composed of keratinocytes with melanocytes at the basal layer that give the skin colour)
  • Dermis (connective tissue, blood vessels etc.)
  • Fat layer (also called the panniculus)

The junction between the epidermis and dermis is called dermo-epidermal junction. It is a complex area composed of many proteins that stick the epidermis to the dermis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diagnose

  • 17 year old woman
  • 12 month of an intensely itchy rash
  • Intermittent lasting less than 24 hours on all parts of the body
    • Expressed suicidal ideation and not attending school
    • No preceding infection
    • All treatment tried so far ineeffective
  • PMH: Nil
  • DH: cetrizine 20mg od
A

Intermittent lasting less than 24 hours on all parts of the body = classic sign of the hives

Urticaria

Describe this type of rash as: Weals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How would you describe this rash?

A

Weals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why do the symtoms in Urticaria occur?

A
  • There are mast cells in the dermis
  • For various reasons (inc autoimmunity) the mast cells become unstable
  • The mast cells are then sending out packets of histamine, which is causing an excitatory reaction

There are lots of types & causes of urticaria

  • Physical
  • Allergicc ingestion - anaphylaxis
  • Angiodema
  • Allergic contact
  • Cold - ice cube test
  • Cholinergic - exercise
  • Drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe Autoimmune Urticaria

A

Antibodies (autoantibodies) bind to mast cells and cause them to de-granulate

Functional IgG autoantibodies are detected in 30-50% of patients with “ordinary” urticaria ad bind to IgE receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do you treat urticaria?

A
  • Most are treated with antihistamine
  • Treat with ciclosporin (immunosupresive treatment) after failure of multiple other modalities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What causes the symtoms in Immune Skin Disease Associated With Autoimmunity? (e.g. Bullous pemphigoid)

(Clinical Scenario “Blisters”) **

A
  • Dermo-epidermal junction represents the boundary between epidermis and dermis. There is a complex group of interacting proteins, among those, an important structure is hemi desmosomes.
  • If antibodies are produced against hemi desmosomes, it allows separation between epidermis and dermis, thus forming blisters.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Diagnose

80 year old lady. Presents with a 4 month history of itch and recent development of blisters.

Significant cognitive impairment due to multiple cerebrovascular accidents prior to onset of her skin problems (hidden clue).

A

Bullous Pemphigoid (BP)

Mechanisms

Bullous pemphigoid is an autoimmune disease due to the formation of IgG antibodies against hemi desmosomal proteins

  • BP is the most likely immunobullous disease you will encounter clinically.
  • It usually presents in older patients over the age of 70 years. Patients complain of an itchy rash and then develop blisters.

BP is due to an autoimmune reaction against two proteins in the hemi desmosomes (BP180 and BP 230), which help stick the epidermis to the dermis.

  • Antibodies to these proteins loosen this adhesion causing epidermis to split from dermis.
  • There are different isoforms of the bullous pemphigoid antigen (BPag), which are
    • (1) neural form (e.g. stroke),
    • (2) skin form,
    • (3) muscular form.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the relationship between Neurological diseases and Bullous Pemphigoid

A

Recent research has shown an association of cerebrovascular injury prior to the onset of Bullous Pemphigoid in some patients.

  • In stroke, blood brain barrier is impaired because of cerebrovascular accident,
  • This allows blood mixing with brain tissue, autoantibodies are then produced.
  • Thereofore, cross over reaction occurs in the skin between neural form of antibodies against BP skin antigen at the hemidesmosome protein.
  • This leads to weakening of epidermis attachment to dermis, and formation of blisters and BP.

There are strong associations between specific neurological diseases and later development of bullous pemphigoid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do the symptoms arise in Pemphigus Vulgaris (PV)

A

Pemphigus vulgaris (PV) is a rare disorder but it is helpful to contrast it with BP.

An autoimmune disease due to IgG autoantibodies against keratinocytes desmosome

PV presents in y_ounger patients_ and depending on the pemphigus sub-type can also involve mucous membranes as well as the skin.

  • Keratinocytes are anchors by desmosome, which forms epidermis.
  • PV is due to an autoimmune reaction due to I_gG autoantibodies desmogleins proteins in desmosomes_

You can then understand why PV produces “shallow” blisters and skin erosions. This is because immune “attack” is within the epidermis (rather than tense blisters seen in BP where immune “attack” is at the dermo-epidermal junction).

  • It commonly affects central back and central chest.
  • It can also affect _oral mucos_a, since keratins are expressed within oral mucosa, which are similarly affected by this disorder. This leads to painful mouth ulcerations.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name some immune skin deases associated with autoimmunity

A

1) Bullous Pemphigoid
2) Pemphigus Vulgaris

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe Direct Immunoflorescence

A

Direct immunofluorescence technique helps to decide where immune “attack” (antibody) is occurring. It is used routinely and diagnostically in the laboratory. Small pinch biopsy is taken where small core of skin is taken under local anesthetics.

  • Anti-human antibodies with a _fluorescing tag a_re directed against the antibodies causing BP and PV.
  • Since tagged autoantibodies are attached to antigens, staining will occur at the site of immune reaction.
  • For bullous pemphigoid (BP), li_near deposit of IgG_ at dermo-epidermal junction.
  • For pemphigus vulgaris (PV), there is _intra-epidermal IgG deposition (_within epidermis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Compare between Bullous Pemphigoid and Pemphigus Vulgaris

A

BP

  • Pemphiogid (common)
  • Full thickness blisters
  • “Attack” at dermo-epidermal junction

PV

  • Pemphigus (rare)
  • Superficial blisters and erosions
  • “Attack” within the epidermis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the Epidermis

What happens when the epidermis fails?

A

Epidermis are like a brick wall.

  • If keratinocytes and binding proteins are healthy, antigens are u_nable to penetrate the skin._
  • If epidermis is dilapidated and broken, it is possible for antigens to penetrate the epidermis, e.g. atopic eczema.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the clinical observations of Eczema?

A

Eczema/Dermatitis

Atopic eczema is a common condition in New Zealand children. It usually improves with age and most, but not all, are resolved by adulthood.

A careful clinical observation was that the skin of patients with atopic dermatitis is dry and similar to a group of genetic disorders called ichthyosis (derived from the ancient Greek word for fish, think scaly).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the Mechanism of action for Atopic eczema

A

Epidermis is divided into several layers, one of those are granular layer (keratinocytes containing lots of granule). One of those granular component is profilaggrin, which is converted to filaggrin. This forms natural moisturizing factor, essential for integrity of epidermis.

Some patients with atopic eczema have been found to have a genetic mutation for a protein called filaggrin, which forms a natural moisturiser in skin.

  • The mutation means the n_atural moisturiser effect is diminished,_ so the barrier function of the skin is impaired.
  • This means that antigens can penetrate the skin more easily, leading to immunological reactions.

Patients with a _filaggrin mutatio_n are far more likely to have atopic dermatitis, which have a higher prevalence of allergy compared to those who do not.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

A 16 year old girl who plays hockey presented with dermatitis around her shoulders.(most ezcema is around the elbows and behind the knees)

She had childhood atopic dermatitis which had resolved (epidermial barrier function likely impaired).

A

Ezcema is confined to shoulders (scratched and inflamed). It is s_ymmetrical distribution_ (unlikely to be natural causes). This is due to allergy to hockey uniform (neoprene).

Diagnosis is allergic contact dermatitis to neoprene, most likely s_econdary to thiourea derivatives_ (thiourea helps vulcanization of neoprene rubber making it more stable and pliable).

-Undergo Patch Testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is Patch Testing?

A

In the clinic, an investigation called patch testing is undertaken to determine which antigens are important. Strips with antigens are attached in groups of 10 to patient’s back for two days.

Severe reactions, especially hand dermatitis, can require a change of occupation. In these cases, it is important to work with the accident compensation corporation (ACC).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
  • Patients with atopic dermatitis can be more susceptible to __________________.
  • Defects in the__________ may account for other allergies in atopic dermatitis.
  • _____________ testing uses _________ to provoke the dermatitis on the back. Patient can avoid the antigen if it is identified.
A
  • Patients with atopic dermatitis can be more susceptible to allergic contact dermatitis.
  • Defects in the epidermal barrier may account for other allergies in atopic dermatitis.
  • Patch testing uses purified antigen to provoke the dermatitis on the back. Patient can avoid the antigen if it is identified.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Why might patients be immunosuppressed?

A

The skin is susceptible to the effects of immunosuppression. Competent immune system is needed to prevent skin infection and skin cancer.

There are several reasons why a patient may be immunosuppressed including:

  • Due to the effects of treatment of disease,
    • _​_e.g. some patients with bullous pemphigoid need agents (prednisone, azathioprine, methotrexate) to control their blistering
  • Because of the effect of disease,
    • e.g. congenital immunodeficiency states, severe combined immunodeficiency, HIV
  • Due to the effect of drugs required for organ transplantation,
    • e.g. renal transplants, bone marrow transplant

The effect of immunosuppression on the skin can be either infection or neoplasia.

Chronically immunosuppressed patients are at risk of skin cancer as natural immunological surveillance mechanisms are suppressed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

If a man comes in with

  • Rash (widespread)
  • Pulpuric- bled into it
  • Immunosuppressed

What should you do to make a diagnosis?

A 55 year old man presents to the emergency department with a painful rash. Three years ago, he underwent a liver transplant for cirrhosis (liver thickening) and a hepatoma (growth within liver).

His medication is mycophenolate 1g od; tacrolimus 2mg/1mg mane, nocte

A
  • Swab for virus and bacteria;
  • Skin biopsy for tissue culture;
  • Blood cultures
22
Q

Diagnose

A 55 year old man presents to the emergency department with a painful rash. Three years ago, he underwent a liver transplant for cirrhosis (liver thickening) and a hepatoma (growth within liver).

His medication is mycophenolate 1g od; tacrolimus 2mg/1mg mane, nocte

A

This patient is immunosuppressed due to transplant, therefore prone to widespread infection. There is widespread red papullar rash and small blisters affecting the trunk and arms.

Diagnosis is disseminated varicella zoster virus (VZV). Since varicella zoster virus (chicken pox) can lie dormant in nerves after resolution, which can reoccur as shingles.

Shingles follows a dermatomal distribution, and very painful.

Treatment is i_ntravenous acyclovir._

23
Q

Diagnose

Why is this patient at risk of skin cancer?

A

Diagnosis is epidermodysplasia verruciformis!!

  • This is due to cutaneous infection with human papilloma virus (wart virus).
  • This patient cannot defend against the infection due to inherited defect of cell mediated immunity (EVER 1 and 2 genes)

Why is this patient at risk of skin cancer?

  • A competent immune system is important to repair ultraviolet induced damage and prevent skin cancer
  • Some types of HPV are oncogenic viruses, e.g. induce cervical cancer.
24
Q

A 65 year old man presents with a lesion on his left ear. It has been growing larger in the last 5 months. He underwent a renal transplant 5 years ago and his current medication is prednisone 5mg od, tacrolimus 3mg bd

Diagose

A

There is eroded exophytic moist module around tip of left ear. Lesion is squamous cell carcinoma.

  • This is on tip of his ear due to higher sun exposure. When the sun shines on the skin, it damages the nucleus of keratinocytes (most cells in epidermis). Therefore, skins around face are vulnerable sites.
  • Usually in immunocompetent patients, there are immune surveillance mechanisms to repair UV damage. Immunosuppressed patients have impaired UV damage repair.
  • The cumulative damage of UV exposure leads to squamous cell carcinoma, and other skin cancers.
25
Q

Diagnose

A

Vitiligo

Vitiligo is a long term skin condition characterized by p_atches of skin losing pigmented melanocytes symmetrically._

  • Patches of skin affected become white and usually have sharp margins.
  • Patches are symmetrical due to migration of neural crest cells (include melanocytes) embryologically.

There is evidence of innate immune mechanisms in vitiligo.

26
Q

What is hypersensitivity and what are the 4 types of hypersensitivity?

A

Hypersensitivity is over-reactive immune response resulting in host pathology. It has traditionally been divided into four types of reaction (Gell and Coombs classification).

  • Type I (IgE-Mediated) Hypersensitivity
  • Type II (Antibody-Mediated) Hypersensitivity​
  • Type III (Immune Complex-Mediated) Hypersensitivity
  • Type IV (Cell-Mediated (Delayed Type, DTH)) Hypersensitivity
27
Q

Describe Mast Cell Degranulation

A
  • In our blood there are Basophils that differentiate into Mast cells in our tissues and mucosal surfaces
  • The Mast cells have FcE receptors and these bind with high affinity to Fc part of IgE
  • The Mast cells are therefore always coated with a sample of IgE from blood
  • If you meet the antigen that binds to the IgE, then the antigen corss-links with the IgE molecules, and trigger the Mast cell to release the contents of the cytoplasmic granules = Mast Cell Degeneration
28
Q

What are the consequences of Mast cells Degranulation?

A

1) Chemoattractants
2) Activators

  • Vasodilation
  • Complement
  • Platelets

3) Spasmogens

  • Smooth Muscle contraction
  • Mucus secretion
29
Q

What are some triggers to Mast Cell Degranulation?

A

1) Antigen crosslinks IgE on mast cells in tissues
2) Drugs
3) C3a and C5a (complement system)

30
Q

Describe the Mechanism of Action of Type 1 Hypersensitivity

A

Type I hypersensitivity occurs when divalent allergen crosslinks two IgE molecules, previously passively bound to high affinity Fcε receptors on mast cells in tissues.

It is also triggered by C3a and C5a, some drugs.

Mast cell mediators are then released via degranulation. It can be pre-formed mediators or newly-formed mediators.

  • Granule-associated pre-formed mediators include histamine, heparin, enzymes (tryptase, β-glucosaminidase), chemotactic and activating factors (eosinophil chemotactic factor, (ECF), neutrophil chemotactic factor (NCF) and platelet activating factor (PAF))
  • Newly formed mediators include lipoxygenase pathway products (SRS (LTC4 and LTD4) and leucotrienes (LTB4)), cyclooxygenase products)(prostaglandins, thromboxanes)

Main functions are chemoattractants, activators (vasodilatation, vascular leakiness, complement, platelets, pruritus) and spasmogens (smooth muscle contraction, mucus secretion). These may be localised.

31
Q

What are some common causes of allergies?

A
  • Rhinitis caused by house dust mite, pollens, animal dander
  • Insect stings caused by proteins in venom, anaphylaxis is common
  • _Food allergie_s caused by wheat protein, milk proteins, peanuts, strawberries
  • _Small molecules i_nclude penicillin, codeine, morphine
32
Q

Where are the common sites of allergies?

A

The effects depend on which part of the body is involved:

  • Respiratory tract include
    • allergic rhinitis (hay fever, perennial rhinitis);
    • sinusitis (inflamed nasal sinuses, ?secondary bacterial infection);
    • asthma (allergic component very common, severe asthma maybe fatal)
    • conjunctivitis
  • Eyes include
    • allergic conjunctivitis (inflamed conjunctiva in eyes)
  • Skin include
    • urticaria (wheals);
    • angioedema (deeper skin involvement)
  • Gut include food allergy
    • (diarhoea, abdominal cramps, vomiting)
  • Multiple organs include
    • generalised anaphylaxis (medical emergency)

Patients with a tendency to make _IgE antibodies t_o multiple allergens are called atopic. This runs in families. However, basis for this is poorly understood. One gene may be for a variant of the IgE Fc receptor.

Bronchial reactions to allergens show an immediate (IgE) and late phase (IgG?) reaction.

33
Q

Patients with a tendency to make IgE antibodies to multiple allergens are called _____.

A

Patients with a tendency to make IgE antibodies to multiple allergens are called atopic.

34
Q

How do you Treat Allergies?

A
  • Avoidance is often difficult
  • Antihistamines is common for mild forms e.g. hay fever
  • Corticosteroids is essential for chronic conditions such as asthma
  • Sodium cromoglycate stabilises mast cells
  • Sympathomimetics epinephrine (adrenaline) in anaphylaxis
  • Desensitisation but gradually increasing doses of allergen to induce high affinity IgG antibodies (compete with IgE for allergen)

(Sacads)

35
Q

Describe Type II (Antibody-Mediated) Hypersensitivity

A

In type II hypersensitivity (usually organ-specific autoimmunity), antibodies produced by the immune response bind to antigens (intrinsic or extrinsic) on the patient’s own cell surfaces.

  • Complement fixation,
    • e.g. haemolytic disease of newborn (anti-RhD red cell IgG antibodies), autoimmune haemolytic anaemia
  • Antibody dependent cellular cytotoxicity (ADCC) cells have receptors for Fc portion of Ig molecules and lyse target cells when cross-linked.
36
Q

What type(s) of antibodies can be transported across the placenta?

A

IgG

37
Q

Describe Type III (Immune Complex-Mediated) Hypersensitivity

A

Type III hypersensitivity involves binding of antigen and complementary antigen.

Conformational _change in Ig F_c allows binding and activation of complement.

Direct action of complement split products. Recruitment of other inflammatory cells by soluble mediators.

  • In systemic, classic example is serum sickness, which caused by injection of foreign protein. Complexes deposit in skin (rash), joints (arthritis) and kidney (nephritis).
    • If antibodies appear thwn circulating antigen concentrations are high, Immune complex-induced vasculitis and nephritis can occur
      • Formerly seen with often horse immune globulin given for tetanus. A problem with non-human monoclonal antibodies being used in therapy.
      • Postulated mechanism for vasculitis and for the renal disease seen in SLE.
  • In localized, it occurs in tissues.
    • For example, farmer’s lung is an extrinsic allergic alveolitis caused by inhaled actinomycete fungi, which grow in hay. IgG antibodies from circulation meet this antigen in alveoli. Complement activation and recruitment of inflamed cells
38
Q

Describe how Vasculitis and Nephritis can occur due to Type III hypersensitivity

A
  • Immune complexes may start to change flow in that area
  • Might get some microthrombus formation (due to platelet aggregation)
  • Activation of complement system occurs
  • Cause release of Neutrophils to the site
  • Chemotaxis is released
  • Result = Vascular damage triggered by antibodies.
39
Q

Describe Type IV Hypersensitivity

A

Type IV hypersensitivity is CD4 TH1 cell-mediated. (not antibodies)

It takes 24 to 48 hours.

Classic example is Mantoux reaction to intradermal injection of purified protein derivative of tuberculin, to test for cell mediated immunity against mycobacteria.

  • Used for i_mmune memory assessmen_t, e.g. mumps, candida antigen, as part of investigation of suspected immunodeficiency.
  • Also for mechanism underlying contact sensitivity, e.g. to metals in jewellery.

Initial phase of Mantoux reaction involves antigen uptake, processing, and presentation by dendritic cell in skin, and then antigen presentation to memory Th1 cells in nearby lymph nodes.

_T lymphocyte (_mainly T helper 1 type) secretes cytokines, therefore CD4 Th1 cytokine-mediated inflammation.

  • Lymphocytes and macrophages are recruited and activated.
  • Up-regulation of adhesion molecules and MHC expression on keratinocytes.

Also seen in Contact sensitivity

40
Q

Describe Contact Sensitivity

A
  • In the surface regions, there are dendritic cells.
  • If someone is habitually wearing metal, some may leech into her skin (e.g. nickel)
  • Some may have the property to attach to the surface of the normal proteins in that area
  • This causes a modification of the protein so it has the potential to be antigenic (large enough to cause an immune response)
    • Hapten = small molecule that cannot cause a immune response on its own because it’s too small, but when it attaches to a large immunogenic molecule it can be recognised and generate a response to it.
  • The hapten/antigen is then transproted to the lymph node and T cell stimulation occurs
  • Memory Th1 cells return and provoke an inflammation
41
Q

What is a Hapten?

A

small molecule that cannot cause a immune response on its own because it’s too small, but when it attaches to a large immunogenic molecule it can be recognised and generate a response to it.

a small molecule which, when combined with a larger carrier such as a protein, can elicit the production of antibodies which bind specifically to it (in the free or combined state).

42
Q

Which hypersneitivity types are involved in autoimmunity?

A

1) Type II = Organ-specific
* Antibody-mediated (cytotoxic)
2) Type III = Systemic
* Immune complex-mediated

43
Q

Describe the Mechanism of Tolerance

A

Tolerance of “self” is a central property of normal immune system. If this discrimination is broken, immune system may react to self-structures and cause autoimmune diseases.

Many self-reactive lymphocytes are removed from immune repertoire when they are at an immature stage of development. There are several possible mechanisms:

  • Clonal deletion (central)
    • Complete removal of the self-reacting cells.
    • The dominant mechanism for antigens that are expressed in primary lymphoid organs (thymus and bone marrow).
  • Clonal regulation (peripheral),
    • Where there is no co-stimulation (anergy).
    • Self-reacting lymphocytes still exist, but are usually resistant to stimulation. Important for antigens only found in periphery.
  • Suppression (peripheral),
    • Where self-reacting B and T lymphocytes are present and potentially active, but are kept in check by T regulator cells.
  • Immunological ignorance,
    • Where self-reactive cells present, but do not mount a pathological response when it is not seen by immune system.
      • This is due to (1) _antigens sequestered i_n immunologically “privileged” sites, or (2) lacking adequate T cell help.
      • The immune system needs to see antigens in the context of certain “danger” signals (e.g. infection) before it gets interested.
44
Q

Describe the types of autoantibodies

A
  • Natural IgM is common, and these are low affinity autoantibodies
  • Loss of self-tolerance does not always lead to autoimmune disease.
  • The healthy immune repertoire has some B cells, which have the potential to produce autoantibodies. These have been referred to as “natural” autoantibodies.
    • These are usually IgM autoantibodies, with low titre, and/or low affinity.
    • Otherwise, they are directed against antigens that are not normally accessible in significant amounts (“sequestered” antigens).
  • They are thought to have a regulatory role, or help dispose of breakdown products.

Anti-nuclear antibody (ANA)

  • seen in most patients with systemic lupus erythematosis (SLE).
  • It is common in elderly people

Anti-thyroid antibody

  • Is seen in thyroid disease,
  • Also in 10% of elderly (<2% have thyroid disease).
45
Q

Why don’t most autoantibodies cause disease?

A

Autoantibodies don’t cause clinical diseases because amounts or affinity are low. Perhaps they need “help” from a corresponding self-reactive T helper lymphocyte to get a stronger response going.

  • The antibody is not pathogenic. Many of the antibodies we associate with connective tissue diseases don’t cause the disease. They are merely “smoke from the fire,” with some other process really causing the damage.
  • The patient does have autoimmune disease, but this is still sub-clinical.

Autoimmunity/autoantibodies is common, Autoimmune disease is rare

46
Q

If autoantibodies are common, Why do we present with a autoimmune diseases?

A

Cross Reactions (Autoimmunity Through Molecular Mimicry)

Tolerance can sometimes be by-passed by immunization with a closely cross-reacting antigen. An alternative term for this theory of autoimmune disease is “molecular mimicry”.

  • Mimicry means that T cells think they look the same- not necessarily that they are the same.
  • So HLA haplotypes are important

Antibodies against viral RNA or DNA may cross-react with self RNA or DNA. This may help explain autoantibodies to RNA or DNA in connective tissue disease.

  • Infection with certain bacteria (eg Salmonella, Shigella, Chlamydia) can trigger reactive arthritis.
    • One postulated mechanism is that antigens on the bacteria cross-react with antigens in the joint.
  • Rheumatic fever is thought to be due to cross-reactions between antigens on streptococci and antigens in cardiac muscle.

Similar cross-reactive theories have been put forward for viral infection triggering a wide range of autoimmune diseases.

47
Q

Briefly describe 2 Organ-Specific Autoimmunity Autoimmune Disease

A

1) IDDM = Type 1 Diabetes

  • Cytotoxic T cell attacking B cells in the Islet of Langerhans in the Pancreas
  • Insulin-dependent diabetes mellitus, now known as diabetes mellitus type 1 is an autoimmune disease resulting in the destruction of insulin-producing cells (beta cells).

2) Pernicious Anaemia

  • Pernicious anaemia is due to malabsorption of vitamin B12.
  • This can be due to autoimmune destruction of the gastric parietal cells which p_roduce intrinsic factor (IF)_, or antibodies directed against IF itself.
48
Q

Describe the Systemic Autoimmune Disease

A

Systemic autoimmune disease is due to soluble antigen and antibodies in optimal concentration, leads to precipitation and vessel deposition (type III hypersensitivity).

Overall, kidneys have glomerulonephritis, skin has rash, joints have arthritis.

Examples include systemic l_upus erythematosus (SLE)_, rheumatoid arthritis (RA)

49
Q

Describe the Genetic Predisposition to Autoimmune Diseases

A

Antigen Receptor Genes

  • Immunoglobulin genes for some autoantibodies are encoded in germline. Somatic hypermutation may also be responsible for producing autoantibodies.
  • Some T cell receptor (TCR) Vβ genes are used preferentially by autoreactive T cells.

Antigen Presentation Genes

  • This is associated with _class I (_e.g. HLA-B27) and class II (e.g. HLA-DR2, DR3 and DR4)
    • Many autoimmune patients have HLA-B8, HLA-DR3 haplotype.
    • Rheumatoid arthritis is associated with HLA-DR4, ankylosing spondylitis with HLA- B27.
    • Type 1 diabetes mellitus is associated with a specific amino acid substitution (position 57) in beta chain of HLA-DQ.
  • Several mechanisms may account for these MHC associations, including peptide binding; molecular mimicry; and receptor model.

Complement Genes

  • Human SLE is associated with deficiencies of complement components. This is thought to be due to impaired clearance of immune complexes.

Regulatory Genes

  • These tend to code for proteins involved in regulating immune response (cytokines and co-stimulators)
    • CTLA-4 is a molecule that switches off T cells;
    • TNF and IL-1 are examples of various cytokines and cytokine receptors
50
Q

What are the treatment approaches to autoimmune diseases?

A

Replacement

  • IDDM uses replacement of insulin
  • Hashimoto’s disease uses thyroxin replacement
  • Addison’s disease uses glucocorticoid and mineralocorticoid replacement

Suppression

  • SLE uses immunosuppressive drugs (corticosteroids, azathioprine, cyclophosphamide)
  • Rheumatoid arthritis uses immunosuppressive drugs
    • Corticosteroids
    • Anti-inflammatory drugs (NSAIDS),
    • Monoclonal antibodies include TNF, IL-1, IL-6 antagonists
    • B cell depletion (Mab)

Systemic responses are much more difficult to manage, because you have to target the immune response, rather than replace what has been damaged in the organ specifically.

51
Q

Summarise Hypersensitivity

A

Disease may result from an inappropriate immune response to an otherwise innocuous antigen.

  • Mast cells are triggered by IgE and allergen to release numerous preformed and newly synthesised vascular and inflammatory mediators.
  • IgG and IgM may cause damage by blocking or stimulating receptors, activating complement, or forming immune complexes
  • DTH skin response is a classical manifestation of the T helper and macrophage response.

With the exception of IgE mediated

52
Q

Describe Autoimmunity

A
  • Mechanisms of immunological tolerance include clonal deletion, anergy, ignorance, suppression, and immunological privilege.
  • Autoimmunity is common. Clinical autoimmune disease is rare.
  • Tolerance may be broken by release of sequestered antigens, cross-reactions with microbes, adjuvant-like effects, or abnormal MHC expression.
  • The causes of most human autoimmune diseases are unknown. The clinical spectrum of autoimmune disease is wide.
    *